How Many People Die From a Peanut Allergy?

Fatal peanut allergy reactions are rare but not as rare as you might hope. A meta-analysis of fatal food anaphylaxis data estimated the rate of peanut-induced deaths at roughly 2 per million person-years among allergic individuals, which is actually slightly higher than the rate for food allergies overall.¹ That number sounds small, and in absolute terms it is, but peanut allergy affects millions of people worldwide, and the gap between a survivable reaction and a fatal one often comes down to a single decision made in a matter of minutes.

Why Pinning Down an Exact Death Toll Is Harder Than It Sounds

If you go looking for a simple count of annual peanut allergy deaths in the United States or globally, you will quickly run into a frustrating problem: the numbers are unreliable. One major reason is the way deaths are classified. The international system used on death certificates does not include “anaphylaxis” as a straightforward cause-of-death code. Instead, fatal allergic reactions get scattered across several categories, and many are recorded under vague labels that obscure the true trigger.² A study of anaphylaxis deaths in Brazil found that none of the fatal cases would have been identified if researchers had relied solely on the standard underlying-cause-of-death field on the certificate.³

This means every published estimate of peanut allergy deaths is almost certainly an undercount. Researchers who study these fatalities generally agree that the real number is somewhat higher than official statistics suggest, though how much higher remains an open question. Some deaths may be attributed to asthma, cardiac arrest, or unknown causes when the true culprit was an unrecognized allergic reaction. This coding gap is one reason why most of the credible numbers you see in the literature come from specialized registries and meta-analyses rather than government vital statistics reports.

What Makes a Peanut Reaction Fatal

Not every allergic reaction to peanut is life-threatening. Many people experience hives, mild swelling, or stomach upset and recover without any medical intervention. The reactions that kill tend to involve anaphylaxis, a rapid, whole-body response in which blood pressure drops, airways narrow, and the cardiovascular system struggles to keep up. Research tracking cardiovascular changes during peanut-induced reactions found that stroke volume (the amount of blood the heart pumps per beat) drops measurably during the early stages of a reaction, while heart rate and blood pressure spike as the body tries to compensate.⁴ When that compensatory response fails, cardiovascular collapse follows.

The single factor most consistently linked to fatal outcomes is a delay in using epinephrine. Multiple studies have converged on the same finding: the most common cause of death from food allergy reactions is not the severity of the allergy itself but the failure to administer epinephrine quickly enough.⁵ Epinephrine auto-injectors are widely prescribed, yet they are chronically underused. People hesitate to inject, mistake early symptoms for something less serious, or simply do not have the device within reach.⁶ It is worth noting that while delayed epinephrine is strongly associated with fatal outcomes, timely epinephrine alone does not guarantee survival in every case.⁷ Still, it remains the most important single intervention, and the gap between how often it should be used and how often it actually gets used is one of the most fixable problems in allergy medicine.

Who Is at Greatest Risk

Adolescents and young adults are disproportionately represented in fatal food anaphylaxis cases. There are a few reasons for this. Teenagers are more likely to eat away from home, less likely to carry their epinephrine, and more prone to risk-taking behavior around food. They may also be less willing to speak up about their allergy in social settings, a reluctance that can be deadly in a restaurant or at a party.

Having asthma alongside a peanut allergy is one of the clearest risk multipliers. A diagnosis of both food allergy and asthma has been shown to increase the risk of severe episodes from either condition.⁸ Poorly controlled asthma in particular seems to set the stage for reactions that spiral faster and respond less well to treatment. If you or your child has both conditions, keeping the asthma well managed is one of the most practical things you can do to reduce the danger from an accidental peanut exposure.

Where Accidental Exposures Happen

A study of peanut and tree nut reactions in restaurants and food establishments found that Asian restaurants, ice cream shops, and bakeries were the most commonly cited settings.⁹ Desserts accounted for a large share of reactions. Among people with a known allergy who ordered food for themselves, fewer than half told the establishment about their allergy beforehand. And even when staff at the establishment knew the food contained peanut, the allergen was “hidden” in sauces, dressings, or egg rolls about half the time, making it impossible to identify visually. Roughly one in five reactions came not from the food itself but from cross-contamination through shared cooking or serving equipment.

These findings point to a gap between how people think about allergen avoidance and how it actually plays out in real-world settings. Reading a menu is not enough. The allergen may not be listed, it may be present as a minor ingredient in a sauce, or it may transfer from a shared fryer or cutting board. For people with severe peanut allergy, notifying staff every time and asking specifically about preparation methods is not paranoia; it is the bare minimum.

Biphasic Reactions and the Second Wave

One danger that catches people off guard is the biphasic reaction: a second wave of anaphylaxis symptoms that arrives hours after the initial reaction has seemingly resolved. A systematic review found that biphasic reactions occurred in roughly 5 to 9 percent of anaphylaxis cases, with the second phase hitting an average of about eight hours after the first, though it could come as late as 72 hours.¹⁰ A larger registry-based analysis found that peanut and tree nut allergies were themselves a risk factor for biphasic reactions, with those allergens nearly doubling the odds compared to other triggers.¹¹

This is a major reason why emergency physicians recommend observation periods after treating anaphylaxis. You can feel perfectly fine, leave the emergency room, and then deteriorate hours later when no one is watching. While clinically important second-wave reactions are relatively uncommon at the population level, and one study in an emergency department found they occurred in fewer than 1 percent of allergic reaction visits, the potential severity makes them impossible to dismiss.¹²

How Peanut Compares to Other Food Allergens

Peanut is not the only food allergen that kills, but it accounts for a disproportionate share of fatal reactions. In observational studies, peanut and tree nuts together are responsible for at least 30 to 50 percent of food anaphylaxis deaths, with seafood and cow’s milk also making the list.¹³ Part of this is because peanut protein is potent as an allergen: it tends to trigger severe IgE-mediated reactions more reliably than many other foods. Part of it is exposure: peanut is ubiquitous in processed foods, restaurant cooking, and snack products, which multiplies the opportunities for accidental contact.

The meta-analysis cited earlier found that the peanut-specific mortality rate of about 2 per million person-years slightly exceeded the overall food-allergy mortality rate, reinforcing peanut’s outsized role among food triggers.¹ That said, cow’s milk allergy deaths tend to be underappreciated because milk is not perceived as dangerous in the same way peanut is, and seafood anaphylaxis is particularly significant in certain geographic regions where shellfish consumption is high.

Putting the Risk in Perspective

Numbers like “2 per million person-years” are hard to feel. A systematic review tried to put food anaphylaxis deaths in context by comparing them to other familiar risks: for someone with a food allergy, the chance of dying from that allergy in any given year is at least 100 times lower than the risk of dying from any kind of accident in the general population. Even among children and teenagers, where food allergy deaths are more common, the risk is still at least 10 times lower than the risk of accidental death.¹⁴

This comparison matters because the fear of peanut allergy often far outstrips the statistical reality. That is not to say the fear is irrational; any condition that can kill you unpredictably, especially a child, is genuinely terrifying. But the gap between perceived risk and actual risk has real consequences. It shapes how families restrict their lives, how schools write their policies, and how much anxiety patients carry every day.

The Anxiety Problem

Researchers who study food allergy quality of life consistently find that the psychological toll can be more damaging to everyday well-being than the reactions themselves. The hypervigilance around meals, the limited social interactions, the strained family relationships, and the reluctance to travel all add up to a quality of life burden that is substantial and persistent.¹⁵ Excessive anxiety about accidental cross-contamination is extremely common and contributes to poorer allergy management, not better.¹⁶

Within families, the burden is not evenly distributed. One study found that mothers of children with peanut allergy reported significantly worse psychological and physical quality of life than fathers, along with higher anxiety and stress scores. The children themselves had poorer physical health-related quality of life and more school-related difficulties than their non-allergic siblings.¹⁷ This is the hidden cost that death statistics alone never capture. A condition does not have to kill frequently to reshape how families live.

Early Peanut Introduction and Falling Allergy Rates

For decades, guidelines told parents to delay introducing peanut to young children. That advice turned out to be wrong. Since guidelines shifted to recommending early introduction of peanut-containing foods (generally around four to six months of age for high-risk infants), the rate of new peanut allergy diagnoses has dropped significantly. A large study found that the incidence of peanut-related IgE-mediated food allergy fell by about 35 percent in the period after guidelines changed, and that the benefit held regardless of whether the child had a history of eczema or egg allergy.¹⁸ Peanut even dropped from the most common food allergen to the second most common, surpassed by egg.

This is arguably the biggest development in peanut allergy in a generation. Fewer new cases should eventually translate to fewer severe reactions and fewer deaths, though it will take years for the full effect to show up in mortality data. For parents of young children today, the practical message is straightforward: introducing peanut early, in an age-appropriate form, is one of the most evidence-backed steps available to reduce the chance your child develops the allergy in the first place.

Oral Immunotherapy and Desensitization

For people who already have peanut allergy, oral immunotherapy offers a newer approach. The treatment involves consuming gradually increasing doses of peanut protein under medical supervision, with the goal of raising the threshold at which a reaction occurs. The majority of people who go through the process achieve desensitization, meaning they can tolerate trace amounts of peanut without a severe reaction.¹⁹ This does not cure the allergy; it provides a safety buffer against accidental exposures, which is where most of the real-world danger lives.

The treatment is not without trade-offs. Allergic reactions during the build-up phase are common, and patients need to continue maintenance dosing indefinitely to keep the protection. Still, for families who have been living in constant fear of a stray peanut crumb, even a modest increase in the reaction threshold can be transformative. You go from worrying that a trace amount in a shared kitchen could be lethal to knowing that your child can tolerate a small accidental exposure without a trip to the emergency room.

Geographic Differences in How Peanut Allergy Manifests

Peanut allergy does not look the same everywhere. A study comparing patients from the United States, Spain, and Sweden found striking differences in which peanut proteins triggered the immune response and how severe the clinical picture was. American patients most often reacted to the storage proteins in peanut and presented with more severe symptoms. Spanish patients were more likely to be sensitized to a lipid transfer protein and often developed peanut allergy after first becoming allergic to other plant-derived foods. Swedish patients had the highest rates of sensitization to a birch pollen-related protein in peanut, reflecting the strong birch pollen season in Scandinavia.²⁰

These differences matter because they affect both the severity of reactions and the reliability of diagnostic testing. A person whose peanut allergy is driven by cross-reactivity with birch pollen tends to have milder symptoms than someone sensitized to the major storage proteins. This is one reason why peanut allergy mortality rates vary by region and why a positive skin test or blood test does not tell you, on its own, how dangerous a person’s allergy actually is.

Why Confirming Anaphylaxis After Death Is So Difficult

When someone dies and anaphylaxis is suspected, confirming the diagnosis at autopsy is surprisingly difficult. There are no consistent external signs. The internal findings can overlap with other causes of sudden death. One biomarker that has emerged as a potential tool is tryptase, a protein released by mast cells during allergic reactions. A systematic review of 40 studies found that elevated postmortem tryptase levels were consistently associated with anaphylaxis deaths, but there is still no universally agreed-upon cutoff value, with proposed diagnostic thresholds ranging widely.²¹ Tissue analysis of mast cells in lung and airway samples showed promise but lacked standardized methods.

This diagnostic uncertainty feeds directly back into the undercounting problem. If pathologists cannot reliably confirm anaphylaxis after death, some cases will be classified as something else. It also means that family members may never get a definitive answer about what happened, which compounds the grief. Improving post-mortem diagnostic tools is an active area of forensic research, but standardization across labs and countries remains years away.